Does Olanzapine Warrant Clinical Pharmacokinetic Monitoring in Schizophrenia?

By Schwenger Erin   Dumontet Jane   Ensom Mary H.H.  

Clinical Pharmacokinetics, Vol. 50, Iss. 7, 2011-07 ,pp. : 415-428

Adis International

Access to resources Recommend Favorite

Efavirenz and Nevirapine in HIV-1 Infection: Is There a Role for Clinical Pharmacokinetic Monitoring?

By Dahri Karen   Ensom Mary H.H.  

Clinical Pharmacokinetics, Vol. 46, Iss. 2, 2007-01 ,pp. : 109-132

Adis International

Access to resources Recommend Favorite

Plasma Concentration Monitoring of Busulfan: Does It Improve Clinical Outcome?

By McCune J.S.  

Clinical Pharmacokinetics, Vol. 39, Iss. 2, 2000-08 ,pp. : 155-165

Adis International

Access to resources Recommend Favorite

Cost Analyses Of Adjunct Colony Stimulating Factors For Older Patients With Acute Myeloid Leukaemia: Can they Improve Clinical Decision Making?

By Bennett C.L.   Schumock G.T.  

Drugs & Aging, Vol. 20, Iss. 7, 2003-01 ,pp. : 479-483

Adis International

Access to resources Recommend Favorite

Room to improve oncologists' use of QOL information?

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 329, 2001-01 ,pp. : 10-11

Adis International

Access to resources Recommend Favorite